Please provide your email address to receive an email when new articles are posted on . The MD Anderson Cancer Center initiated universal HCV screening for all new outpatients with a focus on patients ...

June 28, 2010 — The US Food and Drug Administration (FDA) has approved the first rapid blood test for antibodies to the hepatitis C virus (OraQuick HCV Rapid Antibody Test; OraSure Technologies, Inc) ...

PHILADELPHIA (CBS) – It's never easy to learn you have a chronic condition, but it's important to know if there is potential to control that condition or even begin early treatment. Such is the case ...

BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...

The FDA has approved the OraQuick HCV Rapid Antibody Test (from OraSure) to test individuals who are at risk for infection with hepatitis C virus (HCV) and people with signs or symptoms of hepatitis.

An optimized hepatitis C virus screening and linkage-to-care process reduces the number of patients lost to follow-up and improves linkage to care for Medicare, Medicaid, and commercially insured ...

A Phase 1 clinical trial of a human monoclonal antibody that neutralizes the hepatitis C virus (HCV) has begun. The trial will include 30 healthy volunteers and will test the safety and activity of ...

April 24, 2009 (Paris, France) — Someone awaiting heart transplantation who is fitted with a left ventricular assist device (LVAD) may be at increased risk of falsely testing positive for hepatitis C ...

Hepatitis C is a chronic viral infection that doesn’t always cause symptoms, so it’s possible to be infected with the virus for years without feeling ill. (1) The virus spreads through contact with an ...

HCV Treatment in Prison Could Be Key Public Health Measure The lack of a hepatitis C virus (HCV) RNA test for approximately one-half of persons newly reported as HCV infected suggests that testing and ...